National Cancer Institute; Notice of Meeting

• Published date: 23 December 2019
• Record Number: 2019-27582
• Section: Notices
• Court: National Institutes Of Health

Federal Register, Volume 84 Issue 246 (Monday, December 23, 2019)

[Federal Register Volume 84, Number 246 (Monday, December 23, 2019)]
                [Notices]
                [Page 70559]
                From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
                [FR Doc No: 2019-27582]
                -----------------------------------------------------------------------
                DEPARTMENT OF HEALTH AND HUMAN SERVICES
                National Institutes of Health
                National Cancer Institute; Notice of Meeting
                 Pursuant to section 10(a) of the Federal Advisory Committee Act, as
                amended, notice is hereby given of a meeting of the National Cancer
                Institute Clinical Trials and Translational Research Advisory
                Committee.
                 The meeting will be open to the public. The open session will be
                videocast and can be accessed from the NIH Videocasting and Podcasting
                website (http://videocast.nih.gov/).
                 Name of Committee: National Cancer Institute Clinical Trials and
                Translational Research Advisory Committee.
                 Date: March 12, 2020.
                 Time: 11:00 a.m. to 1:00 p.m.
                 Agenda: Strategic Discussion of NCI's Clinical and Translational
                Research Programs.
                 Place: National Institutes of Health, Building 31, Room 11A01,
                31 Center Drive, Bethesda, MD 20892 (Virtual Meeting).
                 Contact Person: Sheila A. Prindiville, M.D., M.P.H. Director,
                Coordinating Center for Clinical Trials, National Institutes of
                Health, National Cancer Institute, Coordinating Center for Clinical
                Trials, 9609 Medical Center Drive, Room 6W136, Rockville, MD 20850,
                240-276-6173, [email protected].
                 Any interested person may file written comments with the
                committee by forwarding the statement to the Contact Person listed
                on this notice. The statement should include the name, address,
                telephone number and when applicable, the business or professional
                affiliation of the interested person.
                 Information is also available on the Institute's/Center's home
                page: http://deainfo.nci.nih.gov/advisory/ctac/ctac.htm, where an
                agenda and any additional information for the meeting will be posted
                when available.
                (Catalogue of Federal Domestic Assistance Program Nos. 93.392,
                Cancer Construction; 93.393, Cancer Cause and Prevention Research;
                93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
                Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
                Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
                Control, National Institutes of Health, HHS)
                 Dated: December 17, 2019.
                Melanie J. Pantoja,
                Program Analyst, Office of Federal Advisory Committee Policy.
                [FR Doc. 2019-27582 Filed 12-20-19; 8:45 am]
                 BILLING CODE 4140-01-P